Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| NCT ID | NCT01678105 |
| Title | A Phase II Study of Dovitinib in Recurrent and/or Metastatic Adenoid Cystic Carcinoma of the Salivary Glands (DOVE) |
| Acronym | DOVE |
| Recruitment | Completed |
| Gender | both |
| Phase | Phase II |
| Variant Requirements | No |
| Sponsors | Ontario Clinical Oncology Group (OCOG) |
| Indications | |
| Therapies | |
| Age Groups: | adult | senior |
| Covered Countries | CAN |
| Facility | Status | City | State | Zip | Country | Details |
|---|---|---|---|---|---|---|
| Tom Baker Cancer Centre | Calgary | Ontario | T2N 4N2 | Canada | Details | |
| Juravinski Cancer Centre | Hamilton | Ontario | L8V 5C2 | Canada | Details | |
| London Health Sciences Centre | London | Ontario | N6A 4L6 | Canada | Details | |
| Ottawa Hospital Regional Cancer Centre | Ottawa | Ontario | K1H 8L6 | Canada | Details |